Julie Stevens

The Oxford-Harrington Rare Disease Centre was launched in 2019 as a partnership between the Harrington Discovery Institute and the University.  The OHC aims to address the vast unmet need in treatment options for the 350 million people worldwide who suffer from a rare disease, of whom half are children. The Centre is directed by Oxford’s Matthew Wood and consolidates the rare disease research that occurs across almost every department of the Medical Sciences Division.

I lead the administration and management of the Centre and the implementation of its aims. 

I am a biochemist and moved into research management from the University’s Department of Biochemistry, where I researched post-translational protein modifications, alongside various college teaching roles.